Moors & Cabot, Inc. Amgen Inc Transaction History

Moors & Cabot, Inc.

$1.85 Billion
Q2 2024

A detailed history of Moors & Cabot, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Moors & Cabot, Inc. holds 20,875 shares of AMGN stock, worth $6.6 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

20,875

Previous 21,794 4.22%

Holding current value

$6.6 Million

Previous $6.2 Million 5.26%

% of portfolio

0.35%

Previous 0.34%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$262.75 - $319.31 $241,467 - $293,445	-919 Reduced 4.22%	20,875 $6.52 Million
Q1 2024 May 08, 2024	BUY	$268.87 - $324.56 $238,487 - $287,884	887 Added 4.24%	21,794 $6.2 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $52,162 - $58,845	204 Added 0.99%	20,907 $6.02 Million
Q3 2023 Nov 07, 2023	BUY	$218.65 - $271.46 $206,186 - $255,986	943 Added 4.77%	20,703 $5.56 Million
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $106,706 - $126,178	-498 Reduced 2.46%	19,760 $4.39 Million
Q1 2023 May 04, 2023	BUY	$225.79 - $275.2 $2,032 - $2,476	9 Added 0.04%	20,258 $4.9 Million
Q4 2022 Feb 09, 2023	BUY	$229.03 - $291.01 $1.68 Million - $2.13 Million	7,319 Added 56.6%	20,249 $5.32 Million
Q4 2022 Feb 06, 2023	SELL	$229.03 - $291.01 $1.4 Million - $1.77 Million	-6,094 Reduced 32.03%	12,930 $3.4 Million
Q3 2022 Nov 07, 2022	BUY	$224.46 - $253.15 $194,831 - $219,734	868 Added 4.78%	19,024 $4.29 Million
Q2 2022 Aug 08, 2022	SELL	$230.71 - $256.74 $57,908 - $64,441	-251 Reduced 1.36%	18,156 $4.42 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $795,292 - $879,801	3,627 Added 24.54%	18,407 $4.45 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $217,773 - $249,222	1,095 Added 8.0%	14,780 $3.33 Million
Q3 2021 Dec 08, 2021	BUY	$212.27 - $248.7 $2.9 Million - $3.4 Million	13,685 New	13,685 $2.91 Million
Q3 2021 Nov 05, 2021	SELL	$212.27 - $248.7 $2.87 Million - $3.37 Million	-13,534 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $31,066 - $34,465	133 Added 0.99%	13,534 $3.3 Million
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $244,544 - $284,977	-1,102 Reduced 7.6%	13,401 $3.33 Million
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $2.74 Million - $3.26 Million	-12,652 Reduced 46.59%	14,503 $3.33 Million
Q3 2020 Nov 09, 2020	SELL	$234.65 - $260.95 $132,577 - $147,436	-565 Reduced 2.04%	27,155 $6.9 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $327,968 - $402,462	1,658 Added 6.36%	27,720 $6.55 Million
Q1 2020 May 12, 2020	SELL	$182.24 - $241.7 $856,528 - $1.14 Million	-4,700 Reduced 15.28%	26,062 $5.28 Million
Q4 2019 Jan 28, 2020	SELL	$189.21 - $243.2 $130,176 - $167,321	-688 Reduced 2.19%	30,762 $7.4 Million
Q3 2019 Oct 22, 2019	BUY	$174.11 - $208.62 $78,001 - $93,461	448 Added 1.45%	31,450 $6.09 Million
Q2 2019 Jul 18, 2019	SELL	$166.7 - $195.41 $49,843 - $58,427	-299 Reduced 0.96%	31,002 $5.7 Million
Q1 2019 May 06, 2019	SELL	$180.87 - $203.88 $5.66 Million - $6.38 Million	-31,301 Reduced 50.0%	31,301 $5.94 Million
Q1 2019 May 01, 2019	BUY	$180.87 - $203.88 $5.46 Million - $6.16 Million	30,191 Added 93.15%	62,602 $11.9 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $73,500 - $85,799	412 Added 1.29%	32,411 $6.3 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $448,587 - $505,722	2,421 Added 8.19%	31,999 $6.63 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $254,886 - $286,292	-1,535 Reduced 4.93%	29,578 $5.45 Million
Q1 2018 May 18, 2018	SELL	$169.43 - $198.0 $145,879 - $170,478	-861 Reduced 2.69%	31,113 $5.3 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $335,216 - $374,539	1,986 Added 6.62%	31,974 $5.56 Million
Q3 2017 Nov 16, 2017	BUY	$167.29 - $191.0 $238,890 - $272,748	1,428 Added 5.0%	29,988 $5.6 Million
Q2 2017 Aug 15, 2017	BUY	N/A	28,560	28,560 $4.91 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.

Account